PVR and cancer: CD155 is overexpressed in many cancers, including lung adenocarcinoma (10), pancreatic cancer (11), ovarian cancer (12), myeloid leukemia (13), neuroblastoma (13, 14), colorectal cancer (14), and cholangiocarcinoma (15).